Investors Overview Overview Investor Relations Investor Relations News Releases Presentations & Events Common Stock Information Stock Quote & Chart Analyst Coverage SEC Filings Corporate Governance Overview Board of Directors Committee Composition Management Team Corporate Factsheet Annual Reports Overview FRONT >> Quick Links Stock Info News Releases SEC Filings Analyst Coverage Presentations & Events Corporate Factsheet News Releases Aug 10 2022 Cyclacel Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update Aug 03 2022 Cyclacel Pharmaceuticals to Release Second Quarter 2022 Financial Results Jun 30 2022 Cyclacel Pharmaceuticals Achieves Key Business Objectives in First Half of 2022 and Continues to Advance Clinical Pipeline FRONT >> News > View All View All News Events Aug 10 2022 at 4:30 PM EDT Second Quarter 2022 Financial Results May 11 2022 at 4:30 PM EDT First Quarter 2022 Financial Results Mar 28 2022 at 4:30 PM EDT Fourth Quarter 2021 Financial Results FRONT > Events - View All View All Events Featured Videos CEO Spiro Rombotis addressing Cancer Resistance Toolkit Email AlertsRSS FeedsPrint Page
Overview FRONT >> Quick Links Stock Info News Releases SEC Filings Analyst Coverage Presentations & Events Corporate Factsheet News Releases Aug 10 2022 Cyclacel Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update Aug 03 2022 Cyclacel Pharmaceuticals to Release Second Quarter 2022 Financial Results Jun 30 2022 Cyclacel Pharmaceuticals Achieves Key Business Objectives in First Half of 2022 and Continues to Advance Clinical Pipeline FRONT >> News > View All View All News Events Aug 10 2022 at 4:30 PM EDT Second Quarter 2022 Financial Results May 11 2022 at 4:30 PM EDT First Quarter 2022 Financial Results Mar 28 2022 at 4:30 PM EDT Fourth Quarter 2021 Financial Results FRONT > Events - View All View All Events Featured Videos CEO Spiro Rombotis addressing Cancer Resistance
Aug 10 2022 Cyclacel Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
Jun 30 2022 Cyclacel Pharmaceuticals Achieves Key Business Objectives in First Half of 2022 and Continues to Advance Clinical Pipeline
